 Katharina Hopp
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney, Autosomal Dominant | 29 | 2025 | 235 | 6.380 |
Why?
| | TRPP Cation Channels | 19 | 2025 | 74 | 3.170 |
Why?
| | Polycystic Kidney Diseases | 10 | 2025 | 71 | 2.480 |
Why?
| | Kidney | 18 | 2025 | 1493 | 1.970 |
Why?
| | Mutation | 14 | 2022 | 4068 | 1.060 |
Why?
| | Energy Metabolism | 4 | 2024 | 925 | 1.010 |
Why?
| | Tryptophan | 2 | 2023 | 175 | 0.730 |
Why?
| | Adaptive Immunity | 2 | 2020 | 169 | 0.660 |
Why?
| | Renal Agents | 1 | 2020 | 5 | 0.630 |
Why?
| | Caloric Restriction | 1 | 2020 | 126 | 0.560 |
Why?
| | Cysts | 5 | 2025 | 111 | 0.560 |
Why?
| | Mice, Inbred C57BL | 15 | 2025 | 5954 | 0.520 |
Why?
| | Disease Models, Animal | 15 | 2025 | 4525 | 0.500 |
Why?
| | Mice | 23 | 2025 | 18218 | 0.460 |
Why?
| | Hyperoxaluria, Primary | 1 | 2015 | 14 | 0.440 |
Why?
| | Hepatocyte Nuclear Factor 1-beta | 1 | 2014 | 4 | 0.440 |
Why?
| | Mutation, Missense | 4 | 2015 | 338 | 0.440 |
Why?
| | Receptors, Vasopressin | 1 | 2014 | 20 | 0.430 |
Why?
| | DNA Mutational Analysis | 3 | 2014 | 409 | 0.430 |
Why?
| | Arginine Vasopressin | 1 | 2014 | 44 | 0.430 |
Why?
| | Genetic Loci | 2 | 2013 | 260 | 0.430 |
Why?
| | Somatostatin | 1 | 2014 | 53 | 0.420 |
Why?
| | Animals | 30 | 2025 | 37800 | 0.420 |
Why?
| | Benzazepines | 1 | 2014 | 35 | 0.420 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2025 | 452 | 0.410 |
Why?
| | Kidney Failure, Chronic | 2 | 2020 | 596 | 0.410 |
Why?
| | Genetic Association Studies | 2 | 2016 | 369 | 0.410 |
Why?
| | Heterozygote | 1 | 2015 | 313 | 0.410 |
Why?
| | Metabolome | 3 | 2022 | 383 | 0.400 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2021 | 914 | 0.390 |
Why?
| | Encephalocele | 1 | 2011 | 12 | 0.340 |
Why?
| | Ciliary Motility Disorders | 1 | 2011 | 24 | 0.340 |
Why?
| | Protein Folding | 1 | 2012 | 277 | 0.330 |
Why?
| | Disease Progression | 5 | 2022 | 2844 | 0.320 |
Why?
| | Sequence Deletion | 1 | 2011 | 190 | 0.320 |
Why?
| | Kidney Diseases | 1 | 2014 | 427 | 0.320 |
Why?
| | Patient Selection | 1 | 2014 | 721 | 0.320 |
Why?
| | Decision Support Techniques | 1 | 2014 | 460 | 0.310 |
Why?
| | Phenotype | 8 | 2022 | 3139 | 0.310 |
Why?
| | Exons | 1 | 2011 | 359 | 0.310 |
Why?
| | Macrophages | 3 | 2025 | 1496 | 0.270 |
Why?
| | Tumor Microenvironment | 3 | 2021 | 728 | 0.250 |
Why?
| | Mice, Transgenic | 3 | 2018 | 2177 | 0.240 |
Why?
| | Antineoplastic Agents, Immunological | 2 | 2019 | 201 | 0.240 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 2 | 2019 | 6 | 0.230 |
Why?
| | Alleles | 3 | 2018 | 881 | 0.230 |
Why?
| | Metabolomics | 2 | 2022 | 722 | 0.230 |
Why?
| | Mice, Knockout | 6 | 2025 | 3106 | 0.230 |
Why?
| | Glomerular Filtration Rate | 3 | 2024 | 764 | 0.230 |
Why?
| | Kynurenine | 2 | 2023 | 103 | 0.220 |
Why?
| | Pedigree | 7 | 2018 | 512 | 0.220 |
Why?
| | Proteins | 1 | 2011 | 1011 | 0.220 |
Why?
| | Lymphoid Tissue | 1 | 2025 | 78 | 0.220 |
Why?
| | Mice, Mutant Strains | 2 | 2022 | 299 | 0.210 |
Why?
| | Ureteral Obstruction | 2 | 2021 | 62 | 0.200 |
Why?
| | Genetic Therapy | 1 | 2025 | 313 | 0.200 |
Why?
| | B7-1 Antigen | 1 | 2023 | 55 | 0.200 |
Why?
| | Fibrosis | 3 | 2021 | 547 | 0.190 |
Why?
| | Tryptophan Oxygenase | 1 | 2023 | 33 | 0.190 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 48 | 0.190 |
Why?
| | Lipoxygenase Inhibitors | 2 | 2021 | 34 | 0.190 |
Why?
| | Lung Neoplasms | 3 | 2021 | 2643 | 0.180 |
Why?
| | Kidney Tubules | 3 | 2019 | 117 | 0.180 |
Why?
| | Humans | 27 | 2025 | 144298 | 0.180 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2021 | 17 | 0.180 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2021 | 20 | 0.180 |
Why?
| | Nephritis | 1 | 2021 | 22 | 0.180 |
Why?
| | Epithelial Cells | 4 | 2025 | 1102 | 0.170 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 1177 | 0.170 |
Why?
| | Antidiuretic Hormone Receptor Antagonists | 2 | 2025 | 10 | 0.170 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 241 | 0.170 |
Why?
| | Male | 24 | 2025 | 72263 | 0.160 |
Why?
| | Databases, Genetic | 1 | 2022 | 247 | 0.160 |
Why?
| | Trehalose | 1 | 2020 | 35 | 0.160 |
Why?
| | Female | 22 | 2024 | 78137 | 0.160 |
Why?
| | Monocytes | 1 | 2023 | 534 | 0.160 |
Why?
| | Combined Modality Therapy | 1 | 2023 | 1263 | 0.160 |
Why?
| | Nutritive Value | 1 | 2020 | 38 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2019 | 425 | 0.150 |
Why?
| | Cilia | 3 | 2022 | 171 | 0.150 |
Why?
| | Naphthyridines | 1 | 2019 | 20 | 0.150 |
Why?
| | Protein Kinase C | 1 | 2020 | 249 | 0.150 |
Why?
| | Chemokines | 1 | 2020 | 217 | 0.150 |
Why?
| | Mosaicism | 1 | 2019 | 73 | 0.150 |
Why?
| | Receptors, Cell Surface | 2 | 2019 | 370 | 0.140 |
Why?
| | Cardiomegaly | 1 | 2020 | 174 | 0.140 |
Why?
| | Orofaciodigital Syndromes | 1 | 2018 | 1 | 0.140 |
Why?
| | Inflammation Mediators | 1 | 2021 | 503 | 0.140 |
Why?
| | Cell Cycle Proteins | 2 | 2019 | 627 | 0.140 |
Why?
| | Ciliopathies | 1 | 2018 | 6 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 565 | 0.140 |
Why?
| | Cell Line | 3 | 2020 | 2821 | 0.140 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 364 | 0.140 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2018 | 26 | 0.140 |
Why?
| | Trans-Activators | 1 | 2020 | 397 | 0.130 |
Why?
| | Sirolimus | 1 | 2019 | 280 | 0.130 |
Why?
| | Microtubule-Associated Proteins | 1 | 2018 | 194 | 0.130 |
Why?
| | Amino Acid Sequence | 4 | 2018 | 2127 | 0.130 |
Why?
| | Energy Intake | 1 | 2020 | 500 | 0.120 |
Why?
| | alpha-Glucosidases | 1 | 2016 | 9 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 548 | 0.120 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2015 | 2 | 0.120 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2015 | 8 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2019 | 781 | 0.120 |
Why?
| | Hypodermoclysis | 1 | 2014 | 4 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 2 | 2022 | 2348 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2020 | 739 | 0.110 |
Why?
| | Adult | 9 | 2024 | 40408 | 0.110 |
Why?
| | Drinking | 1 | 2014 | 44 | 0.110 |
Why?
| | Antidiuretic Agents | 1 | 2014 | 5 | 0.110 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2014 | 13 | 0.110 |
Why?
| | Food | 1 | 2015 | 148 | 0.110 |
Why?
| | Biomarkers | 3 | 2021 | 4248 | 0.110 |
Why?
| | Rats | 4 | 2019 | 5553 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2020 | 842 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2043 | 0.100 |
Why?
| | Cyclic AMP | 1 | 2014 | 205 | 0.100 |
Why?
| | Immunotherapy | 1 | 2018 | 659 | 0.100 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 155 | 0.100 |
Why?
| | Multiprotein Complexes | 1 | 2015 | 171 | 0.100 |
Why?
| | Molecular Chaperones | 1 | 2015 | 181 | 0.100 |
Why?
| | Liver Diseases | 1 | 2016 | 304 | 0.100 |
Why?
| | Signal Transduction | 4 | 2019 | 5182 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 969 | 0.090 |
Why?
| | Gene Knock-In Techniques | 1 | 2012 | 60 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 264 | 0.090 |
Why?
| | Base Sequence | 2 | 2018 | 2171 | 0.090 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 655 | 0.090 |
Why?
| | Animals, Genetically Modified | 1 | 2012 | 245 | 0.090 |
Why?
| | Models, Genetic | 1 | 2014 | 531 | 0.090 |
Why?
| | Amino Acid Substitution | 1 | 2012 | 303 | 0.090 |
Why?
| | Gene Order | 1 | 2011 | 27 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1044 | 0.080 |
Why?
| | Retinitis Pigmentosa | 1 | 2011 | 20 | 0.080 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2917 | 0.080 |
Why?
| | Intracellular Space | 1 | 2011 | 64 | 0.080 |
Why?
| | Time Factors | 1 | 2022 | 7128 | 0.080 |
Why?
| | Cell Membrane | 1 | 2014 | 704 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2019 | 3520 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 778 | 0.080 |
Why?
| | Cytoskeletal Proteins | 1 | 2011 | 155 | 0.080 |
Why?
| | Young Adult | 5 | 2024 | 14092 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2011 | 368 | 0.080 |
Why?
| | Molecular Sequence Data | 2 | 2011 | 2896 | 0.080 |
Why?
| | Protein Transport | 1 | 2011 | 436 | 0.070 |
Why?
| | Penetrance | 1 | 2009 | 30 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 822 | 0.070 |
Why?
| | Gene Dosage | 1 | 2009 | 148 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2021 | 11713 | 0.070 |
Why?
| | Autophagy | 2 | 2020 | 284 | 0.070 |
Why?
| | Child | 6 | 2022 | 22562 | 0.070 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 264 | 0.060 |
Why?
| | Fetus | 1 | 2011 | 800 | 0.060 |
Why?
| | Infant | 3 | 2018 | 10011 | 0.060 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2025 | 13 | 0.060 |
Why?
| | Fibroblasts | 1 | 2011 | 1017 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Child, Preschool | 3 | 2018 | 11767 | 0.060 |
Why?
| | Phosphorylation | 2 | 2019 | 1702 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2015 | 3879 | 0.050 |
Why?
| | Adolescent | 4 | 2021 | 22370 | 0.050 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 20 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2134 | 0.050 |
Why?
| | Receptors, Chemokine | 1 | 2023 | 47 | 0.050 |
Why?
| | Aged | 4 | 2018 | 25901 | 0.050 |
Why?
| | Middle Aged | 5 | 2018 | 35892 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2019 | 2485 | 0.040 |
Why?
| | Endocannabinoids | 1 | 2022 | 57 | 0.040 |
Why?
| | Genetic Background | 1 | 2021 | 16 | 0.040 |
Why?
| | Pravastatin | 1 | 2021 | 44 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 93 | 0.040 |
Why?
| | Apoptosis | 2 | 2019 | 2395 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5862 | 0.040 |
Why?
| | Autophagy-Related Protein 12 | 1 | 2020 | 4 | 0.040 |
Why?
| | Autophagy-Related Protein 5 | 1 | 2020 | 8 | 0.040 |
Why?
| | Inflammation | 2 | 2022 | 2862 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2019 | 4102 | 0.040 |
Why?
| | Major Histocompatibility Complex | 1 | 2021 | 229 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2020 | 46 | 0.040 |
Why?
| | Leukocytes | 1 | 2021 | 291 | 0.040 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2019 | 24 | 0.040 |
Why?
| | rab GTP-Binding Proteins | 1 | 2020 | 76 | 0.040 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 104 | 0.040 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2019 | 12 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 34 | 0.040 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2019 | 26 | 0.040 |
Why?
| | Chemokine CXCL9 | 1 | 2019 | 38 | 0.040 |
Why?
| | Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2019 | 36 | 0.040 |
Why?
| | Aborted Fetus | 1 | 2018 | 1 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 191 | 0.040 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 130 | 0.040 |
Why?
| | Loop of Henle | 1 | 2018 | 1 | 0.030 |
Why?
| | Gene Silencing | 1 | 2019 | 202 | 0.030 |
Why?
| | Uromodulin | 1 | 2018 | 22 | 0.030 |
Why?
| | Pilot Projects | 1 | 2024 | 1880 | 0.030 |
Why?
| | Nephrons | 1 | 1998 | 23 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2019 | 142 | 0.030 |
Why?
| | Mixed Function Oxygenases | 1 | 1998 | 49 | 0.030 |
Why?
| | Ultrasonography | 2 | 2013 | 773 | 0.030 |
Why?
| | Genotype | 2 | 2016 | 1843 | 0.030 |
Why?
| | Cell Lineage | 1 | 2019 | 376 | 0.030 |
Why?
| | Isoenzymes | 1 | 1998 | 297 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1998 | 161 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 435 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 454 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2512 | 0.030 |
Why?
| | RNA Splicing | 1 | 2018 | 286 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 434 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 147 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 390 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2016 | 363 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 312 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1699 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2012 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 167 | 0.030 |
Why?
| | Forecasting | 1 | 2016 | 391 | 0.030 |
Why?
| | Heredity | 1 | 2013 | 12 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1046 | 0.020 |
Why?
| | Family | 1 | 2018 | 678 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2021 | 3595 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2013 | 122 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2013 | 273 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1762 | 0.020 |
Why?
| | Europe | 1 | 2013 | 417 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1314 | 0.020 |
Why?
| | Canada | 1 | 2013 | 429 | 0.020 |
Why?
| | Diagnostic Errors | 1 | 2013 | 177 | 0.020 |
Why?
| | Haplotypes | 1 | 2013 | 490 | 0.020 |
Why?
| | Genetic Testing | 1 | 2013 | 479 | 0.020 |
Why?
| | Family Health | 1 | 2009 | 191 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2113 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1501 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8265 | 0.010 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 1998 | 4 | 0.010 |
Why?
| | Kidney Cortex | 1 | 1998 | 27 | 0.010 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1998 | 35 | 0.010 |
Why?
| | Kidney Medulla | 1 | 1998 | 31 | 0.010 |
Why?
| | Arterioles | 1 | 1998 | 52 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1998 | 333 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 1998 | 127 | 0.010 |
Why?
| | Sex Characteristics | 1 | 1998 | 776 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1998 | 2808 | 0.000 |
Why?
| | Liver | 1 | 1998 | 1884 | 0.000 |
Why?
|
|
Hopp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|